Boxer Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,100,000
| Closed | -$111M | – | 11 |
|
|
2024
Q3 | $111M | Hold |
2,100,000
| – | – | 5.44% | 5 |
|
|
2024
Q2 | $114M | Hold |
2,100,000
| – | – | 5.99% | 3 |
|
|
2024
Q1 | $147M | Hold |
2,100,000
| – | – | 7.27% | 2 |
|
|
2023
Q4 | $175M | Hold |
2,100,000
| – | – | 8.74% | 2 |
|
|
2023
Q3 | $61.9M | Hold |
2,100,000
| – | – | 3.29% | 10 |
|
|
2023
Q2 | $68.5M | Hold |
2,100,000
| – | – | 3.18% | 10 |
|
|
2023
Q1 | $73.9M | Hold |
2,100,000
| – | – | 3.63% | 10 |
|
|
2022
Q4 | $96.2M | Hold |
2,100,000
| – | – | 5.07% | 3 |
|
|
2022
Q3 | $102M | Hold |
2,100,000
| – | – | 5.72% | 2 |
|
|
2022
Q2 | $82.5M | Hold |
2,100,000
| – | – | 5.23% | 2 |
|
|
2022
Q1 | $77.3M | Hold |
2,100,000
| – | – | 3.97% | 7 |
|
|
2021
Q4 | $95.7M | Hold |
2,100,000
| – | – | 3.72% | 6 |
|
|
2021
Q3 | $75.1M | Hold |
2,100,000
| – | – | 2.62% | 8 |
|
|
2021
Q2 | $41.6M | Hold |
2,100,000
| – | – | 1.47% | 16 |
|
|
2021
Q1 | $48.8M | Hold |
2,100,000
| – | – | 1.66% | 15 |
|
|
2020
Q4 | $43.6M | Buy |
+2,100,000
| New | +$43.6M | 1.4% | 20 |
|